CA2246783C - Mcbi analogs of cc-1065 and the duocarmycins - Google Patents

Mcbi analogs of cc-1065 and the duocarmycins Download PDF

Info

Publication number
CA2246783C
CA2246783C CA002246783A CA2246783A CA2246783C CA 2246783 C CA2246783 C CA 2246783C CA 002246783 A CA002246783 A CA 002246783A CA 2246783 A CA2246783 A CA 2246783A CA 2246783 C CA2246783 C CA 2246783C
Authority
CA
Canada
Prior art keywords
mcbi
compound
dna
hours
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002246783A
Other languages
English (en)
French (fr)
Other versions
CA2246783A1 (en
Inventor
Dale L. Boger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of CA2246783A1 publication Critical patent/CA2246783A1/en
Application granted granted Critical
Publication of CA2246783C publication Critical patent/CA2246783C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Auxiliary Devices For And Details Of Packaging Control (AREA)
  • Dc Digital Transmission (AREA)
  • Silicon Polymers (AREA)
CA002246783A 1996-03-08 1997-03-07 Mcbi analogs of cc-1065 and the duocarmycins Expired - Fee Related CA2246783C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1302496P 1996-03-08 1996-03-08
US60/013,024 1996-03-08
PCT/US1997/003641 WO1997032850A1 (en) 1996-03-08 1997-03-07 Mcbi analogs of cc-1065 and the duocarmycins

Publications (2)

Publication Number Publication Date
CA2246783A1 CA2246783A1 (en) 1997-09-12
CA2246783C true CA2246783C (en) 2006-07-11

Family

ID=21757922

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002246783A Expired - Fee Related CA2246783C (en) 1996-03-08 1997-03-07 Mcbi analogs of cc-1065 and the duocarmycins

Country Status (9)

Country Link
US (1) US5985908A (2)
EP (1) EP0888301B1 (2)
JP (1) JP2000506168A (2)
AT (1) ATE301639T1 (2)
AU (1) AU711974B2 (2)
CA (1) CA2246783C (2)
DE (1) DE69733942T2 (2)
ES (1) ES2244991T3 (2)
WO (1) WO1997032850A1 (2)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045411A1 (en) * 1996-05-31 1997-12-04 The Scripps Research Institute Analogs of cc-1065 and the duocarmycins
NZ334344A (en) * 1996-09-12 2000-08-25 Cancer Res Campaign Tech benzo[e]indole and pyrrolo[3,2-e]indole compounds and their use as prodrugs
US6130237A (en) * 1996-09-12 2000-10-10 Cancer Research Campaign Technology Limited Condensed N-aclyindoles as antitumor agents
WO1998025900A1 (en) * 1996-12-13 1998-06-18 Shionogi & Co., Ltd. Compounds having antitumor activity
JP3649617B2 (ja) 1999-03-26 2005-05-18 独立行政法人科学技術振興機構 ２本鎖ｄｎａを切断できる化合物及びその使用方法
JP5010089B2 (ja) * 2000-09-19 2012-08-29 スピロジェン リミテッド Ｃｃ−１０６５およびデュオカルマイシンのアキラルアナログの組成物およびその使用方法
US7626026B2 (en) 2001-02-22 2009-12-01 University Of Bradford Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
JP4862120B2 (ja) * 2001-02-22 2012-01-25 ユニヴァーシティ オブ ブラッドフォード 腫瘍治療のためのプロドラッグとしてのベンズ−インドールおよびベンゾ−キノリン誘導体
US7129261B2 (en) 2001-05-31 2006-10-31 Medarex, Inc. Cytotoxic agents
WO2004035571A1 (en) * 2002-10-15 2004-04-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
AU2005221959C1 (en) * 2004-03-13 2010-06-17 Kyoto University Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same
JP4806680B2 (ja) 2004-05-19 2011-11-02 メダレックス インコーポレイテッド 自己犠牲リンカー及び薬剤複合体
RU2402548C2 (ru) * 2004-05-19 2010-10-27 Медарекс, Инк. Химические линкеры и их конъюгаты
US7714016B2 (en) 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
SI1940789T1 (sl) * 2005-10-26 2012-03-30 Medarex Inc Postopki in spojine za pripravo cc analogov
CA2627190A1 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) 2006-12-28 2013-10-21 梅達雷克斯有限責任公司 化學鏈接劑與可裂解基質以及其之綴合物
CA2678514A1 (en) 2007-02-21 2008-08-28 Medarex, Inc. Chemical linkers with single amino acids and conjugates thereof
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
AU2011243294C1 (en) 2010-04-21 2015-12-03 Syntarga B.V. Novel conjugates of CC-1065 analogs and bifunctional linkers
WO2013048177A2 (ko) 2011-09-28 2013-04-04 세종대학교산학협력단 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
RU2015129800A (ru) 2012-12-21 2017-01-30 Биоэллаенс К. В. Гидрофильные саморазрушающиеся линкеры и их конъюгаты
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
CA2938919C (en) 2014-02-28 2020-12-29 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
SG11201610620UA (en) 2014-06-20 2017-01-27 Bioalliance Cv Anti-folate receptor aplha (fra) antibody-drug conjugates and methods of using thereof
FI3319936T3 (fi) 2015-07-12 2026-03-12 Hangzhou Dac Biotech Co Ltd Silloituslinkkereitä soluun sitoutuvien molekyylien konjugoimiseksi
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
SG11201805557SA (en) 2016-01-08 2018-07-30 Bioalliance Cv Tetravalent anti-psgl-1 antibodies and uses thereof
CA3042442C (en) 2016-11-14 2024-01-02 Hangzhou Dac Biotech Co., Ltd Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses of such conjugates with the linkers
KR102894542B1 (ko) 2020-01-30 2025-12-03 (주)에임드바이오 벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Also Published As

Publication number Publication date
AU711974B2 (en) 1999-10-28
US5985908A (en) 1999-11-16
CA2246783A1 (en) 1997-09-12
EP0888301A1 (en) 1999-01-07
EP0888301B1 (en) 2005-08-10
JP2000506168A (ja) 2000-05-23
EP0888301A4 (en) 2002-05-08
ES2244991T3 (es) 2005-12-16
DE69733942D1 (de) 2005-09-15
ATE301639T1 (de) 2005-08-15
WO1997032850A1 (en) 1997-09-12
AU1990297A (en) 1997-09-22
DE69733942T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
CA2246783C (en) Mcbi analogs of cc-1065 and the duocarmycins
Boger et al. An efficient synthesis of 1, 2, 9, 9a-tetrahydrocyclopropa [c] benz [e] indol-4-one CBI: an enhanced and simplified analog of the CC-1065 and duocarmycin alkylation subunits
AU727608B2 (en) CBI analogs of CC-1065 and the duocarmycins
BE1006343A5 (fr) Derives de l'indole.
EP2406240B1 (en) Inhibitors of beta-secretase
EP1309594B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
Boger et al. Synthesis and Properties of Substituted CBI Analogs of CC-1065 and the Duocarmycins Incorporating the 7-Methoxy-1, 2, 9, 9a-tetrahydrocyclopropa [c] benz [e] indol-4-one (MCBI) Alkylation Subunit: Magnitude of Electronic Effects on the Functional Reactivity
FI66368C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 6,1-dihydro-11-oxodibens(b e)oxepin-2-aettiksyraderivat
US5721267A (en) Chemotherapeutic pyrrolocarbazole derivatives
Boger et al. Design, Synthesis, and Evaluation of CC-1065 and Duocarmycin Analogs Incorporating the 2, 3, 10, 10a-Tetrahydro-1H-cyclopropa [d] benzo [f] quinol-5-one (CBQ) Alkylation Subunit: Identification and Structural Origin of Subtle Stereoelectronic Features That Govern Reactivity and Regioselectivity
EP0894796B1 (fr) Imidazolines substituées par un noyau hétérocyclique, alpha-2 antaginistes
Ling et al. On the reactions of 1, 3-isoquinolinediones with singlet oxygen
CA1251211A (fr) Derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
CA2213054C (fr) Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NZ233002A (en) 3-(aminoalkyl)benzothiopyran derivatives and pharmaceutical compositions
JPH02164882A (ja) スピロ化合物及びその中間体
KR100217466B1 (ko) 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1h-이미다졸-1-일)메틸]-4h-카바졸-4-온의 새로운 제조방법
FR2639944A1 (fr) Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4366868B2 (ja) 光学活性ヘミエステル類の製造方法
KR790001257B1 (ko) 5, 9-β-2치환된 2-테트라하이드로풀푸릴-6, 7-벤조몰판류의 제조방법
CN119790056A (zh) 三并环类衍生物、药物组合物以及应用
Chimichi et al. Hd4: NPh
JPH0320396B2 (2)
JPH1045762A (ja) オキソテトラヒドロインドリジン誘導体の製造法
JPS60139682A (ja) ベンゾチアゼピン誘導体

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed